Alto Neuroscience, Inc. Business Finance Contracts & Agreements

12 Contracts & Agreements
Browse by Subcategory
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
First Amendment to Loan and Security Agreement, by and among the Registrant, K2 HealthVentures LLC, as lender, K2 HealthVentures LLC, as administrative agent for the Lender, and...
Loan Agreements
Alto Neuroscience, Inc.
NY
2025
Warrant to Purchase Stock, dated January 13, 2025, issued to K2 HealthVentures Equity Trust LLC
Warrant Agreements
Alto Neuroscience, Inc.
NY
2025
Amended and Restated Warrant to Purchase Stock, dated January 13, 2025, issued to K2 HealthVentures Equity Trust LLC
Warrant Agreements
Alto Neuroscience, Inc.
NY
2025
Convertible Loan Agreement, by and between the Registrant and The Wellcome Trust Limited, dated as of July 24, 2024
Loan Agreements
Alto Neuroscience, Inc.
DE
2024
2024 Employee Stock Purchase Plan
Stock Agreements
Alto Neuroscience, Inc.
NY
2024
Form of Common Stock Certificate
Stock Agreements
Alto Neuroscience, Inc.
2024
Form of Underwriting Agreement
Underwriting Agreements
Alto Neuroscience, Inc.
NY
2024
Asset Purchase Agreement, by and between the Registrant and Teva Pharmaceutical Industries, Ltd., dated as of October 4, 2021
Purchase Agreements
Alto Neuroscience, Inc.
NY
2024
Assignment and Assumption Agreement, by and between the Registrant and Palisade Bio, Inc. (formerly Seneca Biopharma, Inc., formerly Neuralstem Inc.), dated as of October 18, 2021
Assignment Agreements
Alto Neuroscience, Inc.
CA
2024
Loan and Security Agreement, by and among the Registrant, K2 HealthVentures LLC, as a lender, and the other lenders from time to time party thereto, or collectively the Lender, K2...
Loan Agreements
Alto Neuroscience, Inc.
NY
2024
Warrant to Purchase Preferred Stock, dated December 16, 2022, issued to K2 HealthVentures Equity Trust LLC
Warrant Agreements
Alto Neuroscience, Inc.
NY
2024
Amended and Restated Investor Rights Agreement, by and among the Registrant and certain of its stockholders, dated as of November 20, 2023
Investor Rights Agreements
Alto Neuroscience, Inc.
DE
2024